Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-20

Clinical Trial Update: Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

View source ↗

Summary

A clinical trial is investigating genome-wide association study data in patients with chronic hepatitis B treated with long-acting interferon, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Long-acting Interferon (Interferon)

Snippet

Sponsor: Minghui Li | Conditions: Chronic Hepatitis B | Status: RECRUITING